Sort
261,768 grants matching “gene therapy”
Comprehensive dissection of the CLL genome & phenome to improve patient outcomes
$1,667,862Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · P01 · FY2021 · CA
Immunologic control of HIV-1 through combination bNAbs and biologics.
$1,667,616Marina Caskey · Rockefeller University · U01 · FY2022 · AI
Studies of genetic and metabolic disorders, autism and premature aging
$1,667,480Owen Rennert · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2012 · HD
Gene Therapy for Vaso-occlusive Disorders
$1,667,399Mayo Clinic Coll Of Medicine, Rochester · P01 · FY2003 · HL
Silent Allosteric Modulation of mGluR5 for Safe and Effective Therapy of Alzheimer's Disease
$1,667,255Stephen M Strittmatter · Yale University · U01 · FY2021 · AG
PIDTC Administrative Unit
$1,667,101Jennifer Maxwell Puck · University Of California, San Francisco · U54 · FY2020 · AI
Center for Modeling Tumor Cell Migration Mechanics
$1,666,953David J Odde · University Of Minnesota · U54 · FY2016 · CA
Precision Imaging of Breast Cancer for Guiding Neoadjuvant Endocrine Therapy
$1,666,890Amy Fowler · University Of Wisconsin-Madison · R01 · FY2025 · CA
Protein Expression
$1,666,739Robert Petrovich · National Institute Of Environmental Health Sciences · ZIC · FY2017 · ES
CONSOLIDATED BASIC CANCER RESEARCH PROGRAM
$1,666,681Wistar Institute · P30 · FY2003 · CA
PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study
$1,666,649Christine M Albert · Brigham And Women'S Hospital · R01 · FY2012 · HL
Genetic and Metabolic Fingerprints of Coactivators "Program Project"
$1,666,468Bert W O'Malley · Baylor College Of Medicine · P01 · FY2010 · DK
Center for Adaptive Treatment of Cigarette Addiction
$1,666,107Jed E Rose · Duke University · P50 · FY2016 · DA
New therapeutic vulnerabilities in breast cancer
$1,666,032Kornelia Polyak · Dana-Farber Cancer Inst · P01 · FY2024 · CA
Adjuvant Enhanced Antiviral Immunity
$1,666,026Jeff C Fairman · Juvaris Biotherapeutics, Inc. · U01 · FY2007 · AI
Tumor Hypoxia: Molecular Studies & Clinical Exploitation
$1,665,852Amato J. Giaccia · Stanford University · P01 · FY2010 · CA
Molecular Circuits in the Hematopoietic Stem Cell Niche
$1,665,686George Q Daley · Boston Children'S Hospital · RC2 · FY2021 · DK
Development of Recombinant Toxins to Treat Hematologic Malignancies
$1,665,659Robert Kreitman · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Polymerase theta, genome instability, and cancer
$1,665,611Dale A Ramsden · Univ Of North Carolina Chapel Hill · P01 · FY2024 · CA
Oral Mucosal Immunity in Vulnerable HIV Infected Populations
$1,665,551Aaron Weinberg · Case Western Reserve University · P01 · FY2010 · DE
A system approach to targeting innate immunity in AD
$1,665,226Todd E. Golde · University Of Florida · U01 · FY2014 · AG
Making antibody generation rapid, scalable, and democratic through machine learning and continuous evolution
$1,665,161Chang C Liu · University Of California-Irvine · R01 · FY2021 · CA
BIOCHEMICAL MARKERS IN THE NURSES'HEALTH STUDY COHORT
$1,664,645Brigham And Women'S Hospital · R01 · FY2000 · CA
MSKCC -Cornell Center for Translation of Cancer Nanomedicines.
$1,664,540Michelle S Bradbury · Sloan-Kettering Inst Can Research · U54 · FY2019 · CA
Pathobiology of Asthma
$1,664,380Serpil C. Erzurum · Cleveland Clinic Lerner Com-Cwru · P01 · FY2019 · HL